Ironwood Pharmaceuticals (IRWD) Capital Expenditures (2010 - 2025)

Ironwood Pharmaceuticals has disclosed Capital Expenditures across 16 years of filings, most recently posting -$1000.0 for Q4 2025.

• Capital Expenditures for Q4 2025 came in at -$1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $34000.0 (down 76.06% YoY), and the FY2025 annual result was $34000.0, down 76.06% from the prior year.
• Capital Expenditures came in at -$1000.0 for Q4 2025 at Ironwood Pharmaceuticals, down from $2000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $211000.0 in Q4 2023 to a low of -$27000.0 in Q4 2022.
• The 5-year median for Capital Expenditures is $31000.0 (2025), against an average of $47533.3.
• Across the five-year window, Capital Expenditures tumbled 121.09% in 2022 and surged 881.48% in 2023, its largest moves.
• Ironwood Pharmaceuticals' Capital Expenditures stood at $128000.0 in 2021, then sank by 121.09% to -$27000.0 in 2022, then soared by 881.48% to $211000.0 in 2023, then plunged by 92.42% to $16000.0 in 2024, then slumped by 106.25% to -$1000.0 in 2025.
• The last three Capital Expenditures figures came in at -$1000.0 (Q4 2025), $2000.0 (Q3 2025), and $2000.0 (Q2 2025), per Business Quant data.